article thumbnail

Risk of myocardial infarction and stroke following bloodstream infection: a population-based self-controlled case series

Open Heart

We aimed to determine the risk of myocardial infarction (MI) and stroke after BSI. We included adults with community-acquired BSI between 2010 and 2020. MI and stroke were determined from International Classification of Disease Version 10 coded admissions.

article thumbnail

Predicting the risk of heart failure after acute myocardial infarction using an interpretable machine learning model

Frontiers in Cardiovascular Medicine

Background Early prediction of heart failure (HF) after acute myocardial infarction (AMI) is essential for personalized treatment. The primary endpoint was the occurrence of HF within 3 years after operation.

article thumbnail

Top stories: Cardiac arrest—Patients at risk

HeartRhythm

Curtain etal1 performed an analysis of the VALIANT (Valsartan in Acute Myocardial Infarction) and PARADISE-MI (Prospective ARNi vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI) trials to evaluate whether risk of sudden cardiac arrest (SCA) following acute myocardial infarction (MI) has changed over time.

article thumbnail

Factors related to cardiac rupture after acute myocardial infarction

Frontiers in Cardiovascular Medicine

BackgroundCardiac rupture (CR) after acute myocardial infarction (AMI) is a fatal mechanical complication. The purpose of our study was to discover relevant risk factors for CR after AMI and in-hospital mortality from CR.MethodsIn this study, we enrolled 1,699 AMI cases from October 2013 to May 2020.

article thumbnail

Beta-blockers after percutaneous coronary intervention for acute myocardial infarction and non-reduced left ventricular ejection fraction

Frontiers in Cardiovascular Medicine

Individual outcomes, including all-cause mortality, myocardial infarction, and revascularization, also showed no significant differences between the two groups. After PS matching, the POCE incidence remained similar between the two groups (3.7% vs. 3.4%, HR 1.01, 95% CI 0.76–1.35, 1.35, p = 0.931).

article thumbnail

Prevalence and effects of acute myocardial infarction on hospital outcomes among COVID-19 patients

Coronary Artery Disease Journal

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. Methods Data from the 2020 California State Inpatient Database was used retrospectively. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients.

article thumbnail

Mortality rate of percutaneous coronary interventions in ST-segment elevation myocardial infarction patients under the public health insurance schemes of Thailand

Frontiers in Cardiovascular Medicine

BackgroundIn Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardial infarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems.